Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -7.55% · OPTIONAL
· Medicinal Chemicals & Botanical Products
RESEARCH SNAPSHOTTilray Brands, Inc.'s latest supported as-filed period reports revenue of $915.5M; gross margin moved 141 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -7.55% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 11.46% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 32.90% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 28.45% · CORE
Level · gp.fundamentals.operating_margin
Raw value -6.88% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 0.04% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Gross margin changed -141 basis points from the comparable as-filed period.
Gross profit changed +5.7% from the comparable as-filed period.
Inventory changed +11.0% from the comparable as-filed period.
Net income changed +96.6% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
TLRY · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001140361-26-032052SEC ↗4Aug 7, 2026Period Aug 6, 20260001171843-26-005348SEC ↗4Aug 4, 2026Period Aug 4, 20260001171843-26-005183SEC ↗4Aug 4, 2026Period Aug 3, 20260001171843-26-005173SEC ↗4Jul 31, 2026Period Jul 29, 20260001171843-26-005128SEC ↗4Jul 31, 2026Period Jul 29, 20260001171843-26-005127SEC ↗4Jul 31, 2026Period Jul 29, 20260001171843-26-005126SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 6, 2026Filed Aug 7, 2026 | Gendel MitchellGlobal General Counsel | Open Market PurchaseDirect | 2,500 | $4 | $11,075 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 5.02% · OPTIONAL
Operating income changed +96.5% from the comparable as-filed period.
Operating margin changed +39629 basis points from the comparable as-filed period.
Research & development changed -27.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-05-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001171843-26-005125